Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-96-000267
Filing Date
1996-08-09
Accepted
1996-08-09 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT SC 13G/A 8287
  Complete submission text file 0000930413-96-000267.txt   10134
Mailing Address 75 MAIDEN LANE NEW YORK NY 10038
Business Address 75 MAIDEN LANE NEW YORK NY 10038 2128068800
ALGER FRED MANAGEMENT INC (Filed by) CIK: 0000003520 (see all company filings)

EIN.: 13510833 | Fiscal Year End: 1231

Mailing Address
Business Address 10900 HAMON ST MONTREAL CANADA E6 5146811744
BIOCHEM PHARMA INC (Subject) CIK: 0000867202 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-45089 | Film No.: 96607554
SIC: 2835 In Vitro & In Vivo Diagnostic Substances